Co-trimoxazole-induced erythema annulare centrifugum

Authors

  • Sujit Ponugoti Post-Graduate
  • Haritha Thiruveedhula Professor
  • Swetha Atluri Assistant Professor
  • Haritha Samanthula Professor & HOD

DOI:

https://doi.org/10.66344/jpad.v31i4.1738

Abstract

Erythema annulare centrifugum (EAC) is an infrequent cutaneous disease characterized by figurate erythematous eruptions that enlarge centrifugally at a rate of 1-3 mm/ day with central clearing resulting in an annular or polycyclic appearance. The characteristic skin eruptions of EAC are associated with various underlying systemic disorders, including infections, autoimmune and endocrine diseases, malignancies, and the use of certain drugs like diuretics, non-steroidal anti-inflammatory agents, antimalarials, gold, amitriptyline, finasteride, penicillins, and salicylates, though the causal association has not been established. Lesions usually involve the thighs, legs, and buttocks and are characterized histopathologically by dermal perivascular lymphohistiocytic infiltrate. EAC is a benign self-limited disease.

A 64-year-old man with pulmonary nocardiosis, on treatment with co-trimoxazole, presented with peripherally spreading raised red-coloured eruptions over thighs, buttocks, and arms. He developed similar lesions in the past, which resolved spontaneously. Cutaneous examination revealed multiple discrete annular erythematous plaques over flexural areas, thighs and buttocks. Skin biopsy showed coat-sleeve peri-appendageal inflammatory infiltrate in the dermis. Pulmonary nocardiosis was confirmed by positive cultures from broncho-alveolar lavage and PCR. A diagnosis of erythema annulare centrifugum, deep type, possibly associated with nocardiosis and/or co-trimoxazole, was made. The lesions subsided after stopping co-trimoxazole.

References

1. Kim DH, Lee JH, Lee JY, et al. Erythema annulare centrifugum: Analysis of associated diseases and clinical outcomes according to histopathologic classification. Ann Dermatol.2016;28:257-9.

2. Rustin M, Cerio R. Reactive inflammatory erythemas. In: Griffiths C, Barker J, Bleiker T, Chalmers R, Creamer D., editors. Rook's Textbook of Dermatology. 9th edn. Chichester: Wiley‐Blackwell; 2016. p. 1356-8.

3. Mshrai H, Fallatah B, Alwafi D, et al. Erythema annulare centrifugum (EAC): A case report of annually recurring EAC. J Health Sci.2016;6:74-6.

4. Al Hawsawi K, Alzanbagi H, Almatrafi S, et al. Erythema annulare centrifugum (deep type): A rare case report. Dermatol Open J. 2017;2:4-6.

5. Weyers W, Diaz-Cascajo C, Weyers I. Erythema annulare centrifugum: results of a clinicopathologic study of 73 patients. Am J Dermatopathol.2003;25:451–62.

6. Mandel VD, Ferrari B, Manfredini M, Giusti F, Pellacani G. Annually recurring erythema annulare centrifugum: a case report. J Med Case Rep.2015; 9:236.

Downloads

Published

29.03.2022

How to Cite

1.
Co-trimoxazole-induced erythema annulare centrifugum. J Pak Assoc Dermatol [Internet]. 2022 Mar. 29 [cited 2026 Aug. 1];31(4):749-52. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1738